Search
Syndax Pharmaceuticals Inc
SNDXAdd to Watchlist
19.300USD
+0.300+1.58%
Market hours （ET）Quotes delayed by 15 min
1.71BMarket Cap
LossP/E TTM
Syndax Pharmaceuticals Inc's Company Valuation
Currency: USD Updated: 2026-06-18The current valuation score of Syndax Pharmaceuticals Inc is 7.43, ranking 232 out of 389 in the Biotechnology & Medical Research industry. Its current P/E ratio is -6.80, which is -67.02% below the recent high of -2.24 and -73.38% above the recent low of -11.79.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.
